DAM
GILD icon

DLD Asset Management’s Gilead Sciences GILD Stock Holding History

DLD Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,800
Closed -$2.75M – 376
2025
Q2 		$2.75M Buy
+24,800
New +$2.64M 0.23% 71

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DLD Asset Management's GILD Position: Q2 2026 in Review

DLD Asset Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 2,000 shares worth $253K. The stake represents 0.02% of the portfolio and ranks #286 among its holdings. This is a return to the name: DLD Asset Management previously reported a position in GILD as recently as Q2 2025.

DLD Asset Management first reported a position in GILD in Q2 2025 and has held it in 2 quarters since. The position peaked at $755K in Q2 2025. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • DLD Asset Management held 2,000 shares of Gilead Sciences worth $253K as of Q2 2026.
  • Gilead Sciences was a new DLD Asset Management position in Q2 2026.
  • Gilead Sciences made up 0.02% of DLD Asset Management's portfolio in Q2 2026, its #286 holding.
  • DLD Asset Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 2 quarters since.
  • DLD Asset Management's Gilead Sciences position peaked at $755K in Q2 2025.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on DLD Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.